Wound dressings with anti-microbial and zinc-containing agents

• US 7,799,965 B2
• Filed: 04/11/2007
• Issued: 09/21/2010
• Est. Priority Date: 04/11/2006
• Status: Active Grant

• Current Assignee: Kpr U.S., LLC (Cardinal Health, Inc.)
• Original Assignee: Tyco Healthcare Group LP (Medtronic Plc)
• Inventors: Ward, Kate, Swaniker, Hansen P., Heagle, David G., Tranchemontagne, Alain, Vitaris, Ronald F., Orr, Scott, Shah, Chirag B., Fink, E. David, Dowd, Brian, Mulligan, Sharon A., Patel, Harish A.
• Primary Examiner(s): Bianco; Patricia M
• Assistant Examiner(s): Hawthorne; Ophelia
• Application Number:
  US11/783,668
• Publication Number:
  US 20070255193A1
• Time in Patent Office: 1,259 Days
• Field of Search: 602/48, 602/54, 602/43, 602/44, 602/45, 602/55, 604/310, 604/312, 604/383, 604/368, 604/378, 604/304, 604/358, 604/367, 424443-449
• US Class Current: 602/48
• CPC Class Codes: A61F 13/00063 comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00
• CPC Class Codes: A61F 13/01029 made of multiple layers
• CPC Class Codes: A61F 2013/00463 haemostatic
• CPC Class Codes: A61F 2013/00727 means for wound humidity control
• CPC Class Codes: A61F 2013/0091 with disinfecting or anaesthetics means, e.g. anti-mycrobic
• CPC Class Codes: A61L 15/18 containing inorganic materials
• CPC Class Codes: A61L 15/44 Medicaments
• CPC Class Codes: A61L 15/46 Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
• CPC Class Codes: A61L 2300/102 Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
• CPC Class Codes: A61L 2300/104 Silver, e.g. silver sulfadiazine
• CPC Class Codes: A61L 2300/206 Biguanides, e.g. chlorohexidine
• CPC Class Codes: A61L 2300/404 Biocides, antimicrobial agents, antiseptic agents
• CPC Class Codes: A61L 2300/61 containing two or more active agents in different layers

Abstract

A wound dressing includes one or more layers containing a first anti-microbial agent and/or at least one zinc-containing agent.

Claims

1. A wound dressing comprising a first layer, second layer and third layer wherein each of the first, second and third layers contain at least one anti-microbial agent and at least one zinc-containing agent.

2. The wound dressing of claim 1, wherein the first layer is substantially hydrophilic, and the second and third layers are outer layers and are substantially hydrophobic.

3. The wound dressing of claim 2, wherein the second and third outer layers comprise a hydrophilic finish.

4. The wound dressing of claim 1, wherein the anti-microbial agent comprises one or more of:

PHMB, PHMB derivatives, PEHMB, silver, copper and combinations thereof.

5. The wound dressing of claim 4, wherein a zinc-containing agent comprises one or more of zinc alginate and zinc aspartate.

6. The wound dressing of claim 1, further comprising a delivery agent for containing and releasing at least one of the agents.

7. The wound dressing of claim 6, wherein the delivery agent comprises one or more of:

a hydrogel, powdered starch, a dissolvable phosphate glass or a starch film.

8. The wound dressing of claim 1, wherein one or more layers are formed, at least in part, by one or more of:

natural fibers, synthetic fibers, cellulose, cotton, Rayon, Nylon, acrylic, polyester, polyurethane, polyurethane foam, a hydrogel, a starch film, calcium alginate an absorbable material and combinations thereof.

9. The wound dressing of claim 1, further comprising one or more of:

a therapeutic agent, an organoleptic agent, a growth factor, an analgesic, a tissue scaffolding agent, a haemostatic agent, a protein inhibitor, collagen, enzymes, an anti-thrombogenic agent, an anesthetic, an analgesic, an anti-inflammatory agent, an anticancer agent, a vasodilation substance, nitric oxide, petroleum jelly, vitamins, taurine, capsaicin, menthol, a wound healing agent, an angiogenic agent, an angiostatic agent, an immune boosting agent, a skin sealing agent, an agent to induce directional bacterial growth, an agent to impart bacteriocidal or bacteriostatic activity, an electron transfer agent to destabilize or destroy the metabolic action of microbes and/or biofilm formation, and combinations thereof.

10. The wound dressing of claim 1, further comprising an adhesive.

11. The wound dressing of claim 1, further comprising at least one of the anti-microbial agent and the zinc-containing agent disposed in a pattern on at least one of the layers.

12. The wound dressing of claim 1, wherein at least one layer is formed from calcium alginate and contains a zinc-containing agent and PHMB.

13. The wound dressing of claim 1, wherein at least one layer is formed from cotton fiber, at least one layer is formed from a foam, and at least one layer is formed from a film.

14. The wound dressing of claim 1, wherein the at least once zinc containing agent comprises zinc aspartate.

15. The wound dressing of claim 1, wherein at least one of the first, second or third layers is a skin-contacting layer.

16. A wound dressing comprising a first layer and a second layer, wherein the first layer is disposed on a first side of the dressing adapted to be applied to the wound surface, the first layer containing the at least one anti-microbial agent;

and the second layer is adjacent to the first layer, and disposed on a side thereof opposite the first side of the dressing, the second layer containing the at least one zinc-containing agent,

wherein the anti-microbial agent comprises one or more of;

PHMB, PHMB derivatives, and PEHMB.

17. The wound dressing of claim 16, further comprising a third layer, wherein the first layer is substantially hydrophilic, and the second and third layers are outer layers and are substantially hydrophobic.

18. The wound dressing of claim 17, wherein the second and third outer layers comprise a hydrophilic finish.

19. The wound dressing of claim 16, wherein the anti-microbial agent further comprises silver, copper and combinations thereof.

20. The wound dressing of claim 19, wherein a zinc-containing agent comprises one or more of zinc alginate and zinc aspartate.

21. The wound dressing of claim 16, further comprising a delivery agent for containing and releasing at least one of the agents.

22. The wound dressing of claim 21, wherein the delivery agent comprises one or more of:

a hydrogel, powdered starch, a dissolvable phosphate glass or a starch film.

23. The wound dressing of claim 16, wherein one or more layers are formed, at least in part, by one or more of:

natural fibers, synthetic fibers, cellulose, cotton, Rayon, Nylon, acrylic, polyester, polyurethane, polyurethane foam, a hydrogel, a starch film, calcium alginate an absorbable material and combinations thereof.

24. The wound dressing of claim 16, further comprising one or more of:

a therapeutic agent, an organoleptic agent, a growth factor, an analgesic, a tissue scaffolding agent, a haemostatic agent, a protein inhibitor, collagen, enzymes, an anti-thrombogenic agent, an anesthetic, an analgesic, an anti-inflammatory agent, an anticancer agent, a vasodilation substance, nitric oxide, petroleum jelly, vitamins, taurine, capsaicin, menthol, a wound healing agent, an angiogenic agent, an angiostatic agent, an immune boosting agent, a skin sealing agent, an agent to induce directional bacterial growth, an agent to impart bacteriocidal or bacteriostatic activity, an electron transfer agent to destabilize or destroy the metabolic action of microbes and/or biofilm formation, and combinations thereof.

25. A wound dressing comprising at least one layer, wherein one or more layers comprise a combination of fibers, the combination of fibers comprising at least a first fiber and a second fiber, wherein the first fiber comprises at least a first anti-microbial agent, and the second fiber comprises at least a zinc-containing agent.

26. The wound dressing of claim 25, wherein one or more layers comprise a homogenous blend of fibers.

27. The wound dressing of claim 25, wherein the amount of first fiber present in the wound dressing is different than the amount of second fiber present in the wound dressing.

28. The wound dressing of claim 25, wherein the density of either the first fiber, second fiber, or both, vary along a concentration gradient.